Dr. Hasanain Habeeb Ghali — Iraqi Pediatric Hematologist/Oncologist, University of Baghdad

Dr. Hasanain Habeeb Ghali is a distinguished Iraqi physician, academic, and consultant specializing in Pediatric Hematology and Oncology. Born in Iraq in 1978, Dr. Ghali received his foundational medical education at the University of Baghdad College of Medicine, graduating with his Bachelor of Medicine, Bachelor of Surgery (M.B.Ch.B.) in 2002. He officially began his service with the Ministry of Higher Education and Scientific Research on January 9, 2003.

His commitment to specializing in child health led him to pursue multiple advanced qualifications in pediatrics. He obtained the Diploma in Child Health (D.C.H.) from the University of Baghdad in 2009. Concurrently, he achieved the Fellowship of the Iraqi Board for Medical Specializations (F.I.B.M.S.) in Pediatrics in the same year, signifying his expertise as a specialist pediatrician. Dr. Ghali further enhanced his qualifications by obtaining an additional F.I.B.M.S. in his field, demonstrating a continuous drive for excellence in complex pediatric care, particularly in managing childhood cancers.

Dr. Ghali's professional career has been firmly rooted in both academic instruction and tertiary clinical care in Baghdad. Since 2009, he has served as an Assistant Professor in the Pediatrics Branch at the University of Baghdad College of Medicine, playing a role in shaping the professional and ethical standards of future Iraqi medical professionals.

Clinically, Dr. Ghali holds a critical role as a Consultant in Pediatric Hematology and Oncology at the Teaching Children's Protection Hospital (part of Medical City, Baghdad). From 2009 to 2012, he served as a Fellow in the specialized Hemato-Oncology Unit, establishing deep expertise in the diagnosis and management of pediatric cancers.

A significant, quantifiable achievement in his career involves a public health effort that directly improved national cancer outcomes. Dr. Ghali was part of a team that conducted a retrospective analysis of 1,415 cases of Acute Lymphoblastic Leukemia (ALL) in Iraqi children treated between 2000 and 2016. This analysis directly contributed to implementing updated and optimized treatment protocols across the country, resulting in a marked improvement in ALL cure rates in Iraq, rising from approximately 80% to 91%.

Dr. Ghali's research interests are primarily focused on blood disorders and malignant tumors in children. His specific areas of focus include the epidemiology and treatment strategies for Acute Lymphoblastic and Myeloid Leukemia (ALL/AML), various hematological tumors, and solid tumors in children.

His commitment to research extends to the institutional level. He is an active member of the Hemato-Oncology team at the Children's Protection Hospital and participates in reviewing and discussing Iraqi Board research theses at sister institutions, reflecting his dedication to advancing evidence-based practice in Iraq's postgraduate medical training system.

Dr. Ghali's professional standing is marked by the attainment of rigorous qualifications within the Iraqi medical system, notably the F.I.B.M.S. and D.C.H. degrees. His most significant recognized professional contribution is his role in the team that raised national cure rates for childhood leukemia from 80% to 91%, an achievement with a direct and measurable positive impact on public health. He is also recognized within the academic community of the University of Baghdad for his excellence in teaching and his ethical dedication.

The specialized nature of Pediatric Hematology and Oncology requires patients to easily locate and connect with highly qualified consultants. To find practitioners with similar training and specializations in Iraq, patients are encouraged to use reputable, verified platforms. Find similar specialists on Doctoury's verified medical directory.